How big is the Australia And New Zealand Diabetes Devices Market?

The Australia And New Zealand Diabetes Devices Market size is expected to reach USD 1.14 billion in 2024 and grow at a CAGR of 2.70% to reach USD 1.30 billion by 2029. Read More

What is the current Australia And New Zealand Diabetes Devices Market size?

In 2024, the Australia And New Zealand Diabetes Devices Market size is expected to reach USD 1.14 billion. Read More

Who are the key players in Australia And New Zealand Diabetes Devices Market?

Novo Nordisk, Dexcom, Abbott, Sanofi and Medtronic are the major companies operating in the Australia And New Zealand Diabetes Devices Market. Read More

What years does this Australia And New Zealand Diabetes Devices Market cover, and what was the market size in 2023?

In 2023, the Australia And New Zealand Diabetes Devices Market size was estimated at USD 1.11 billion. The report covers the Australia And New Zealand Diabetes Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia And New Zealand Diabetes Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Australia And New Zealand Diabetes Devices Market Share

Statistics for the 2023 & 2024 Australia And New Zealand Diabetes Devices market share, created by Mordor Intelligence™ Industry Reports. Australia And New Zealand Diabetes Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Australia And New Zealand Diabetes Devices Industry

The Australia and New Zealand diabetes devices market is highly fragmented, with multiple players. Market leaders such as Eli Lilly, Sanofi, Novo Nordisk, and Dexcom are focusing on product launches and technological collaboration to increase their foothold in the market.